Related references
Note: Only part of the references are listed.Randomized Comparison of Intensified and Standard P2Y12-Receptor-Inhibition Before Elective Percutaneous Coronary Intervention The SASSICAIA Trial
Julinda Mehilli et al.
CIRCULATION-CARDIOVASCULAR INTERVENTIONS (2020)
Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection vs Conventional Clopidogrel Therapy on Ischemic Outcomes After Percutaneous Coronary Intervention: The TAILOR-PCI Randomized Clinical Trial
Naveen L. Pereira et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Ticagrelor versus clopidogrel in elective percutaneous coronary intervention (ALPHEUS): a randomised, open-label, phase 3b trial
Johanne Silvain et al.
LANCET (2020)
2018 ESC/EACTS Guidelines on myocardial revascularization
Franz-Josef Neumann et al.
EUROPEAN HEART JOURNAL (2019)
Efficacy and Safety of Loading Doses With P2Y12-Receptor Antagonists in Patients Without Dual Antiplatelet Therapy Undergoing Elective Coronary Intervention
Jesus Piqueras-Flores et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2019)
Prevention of minor myocardial injury after elective percutaneous coronary intervention: comparison of ticagrelor versus clopidogrel
Huseyin Goksuluk et al.
ACTA CARDIOLOGICA (2018)
Randomized Comparison of Different Thienopyridine Loading Strategies in Patients Undergoing Elective Coronary Intervention The ExcelsiorLOAD Trial
Willibald Hochholzer et al.
JACC-CARDIOVASCULAR INTERVENTIONS (2016)
Randomized, Double-Blind, Dose-Finding, Phase II Study of Prasugrel in Japanese Patients Undergoing Elective Percutaneous Coronary Intervention
Takeshi Kimura et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2015)
Treatment Patterns and Outcomes in Patients Undergoing Percutaneous Coronary Intervention Treated With Prasugrel or Clopidogrel (from the Swedish Coronary Angiography and Angioplasty Registry [SCAAR])
Peter Damman et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
2014 ESC/EACTS Guidelines on myocardial revascularization
Stephan Windecker et al.
EUROPEAN HEART JOURNAL (2014)
A Pilot Study of Prasugrel Followed by Post-Procedural Maintenance with Clopidogrel in Patients Receiving Percutaneous Coronary Intervention
Mina M. Benjamin et al.
JOURNAL OF INTERVENTIONAL CARDIOLOGY (2013)
Randomized Double-Blind Assessment of the ONSET and OFFSET of the Antiplatelet Effects of Ticagrelor Versus Clopidogrel in Patients With Stable Coronary Artery Disease The ONSET/OFFSET Study
Paul A. Gurbel et al.
CIRCULATION (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Evaluation of prasugrel compared with clopidogrel in patients with acute coronary syndromes: design and rationale for the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel Thrombolysis In Myocardial Infarction 38 (TRITON-TIMI 38)
Stephen D. Wiviott et al.
AMERICAN HEART JOURNAL (2006)
Clopidogrel loading dose (300 versus 600 mg) strategies for patients with stable angina pectoris subjected to percutaneous coronary intervention
RM Wolfram et al.
AMERICAN JOURNAL OF CARDIOLOGY (2006)
Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention - A randomized controlled trial
SR Steinhubl et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
The CURE trial: Using clopidogrel in acute coronary syndromes without ST-segment elevation
GP Gerschutz et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2002)
Share Paper
